Jim Cramer says to use Wednesday’s rally to reposition into profitable stocks

Jim Cramer says to use Wednesday’s rally to reposition into profitable stocks


CNBC’s Jim Cramer urged investors to use the market’s rally on Wednesday to recalibrate their portfolios.

“Use this moment to pivot yourself. Get out of the stocks I’ve been railing against for a full year,” he said, adding, “Get into the stocks of companies that make things and do stuff at a profit and return some of that to you.”

Stocks rose on Wednesday after Federal Reserve Chair Jerome Powell signaled that the central bank will ease back its brisk pace of interest rate increases as soon as December, though he maintained there’s still a way to go before prices stabilize.

Cramer reminded investors that while Powell’s remarks bode well for investors hoping the Fed will engineer a soft landing, it doesn’t mean that the macroeconomic headwinds battering companies’ balance sheets have disappeared.

In other words, investors should still exercise caution and avoid companies that are on the path to continue hemorrhaging cash.

“If your company has just laid off a bunch of people because it’s losing so much money, that’s not where you want to be. If your company doesn’t return capital because it doesn’t have any capital to return, that’s not where you want to be,” he said.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More